A recent case report highlights that pairing a targeted nerve procedure with an IV medication drip can provide lasting relief for severe shingles pain that fails to respond to standard medications. This innovative two-step approach successfully conquers the stubborn, debilitating nerve pain known as postherpetic neuralgiaThe findings of the case report are published in the Indian Journal of Pain in June 2026 by Dr. Dhanya Ravindran and colleagues from Bhopal Spine and Pain Relief Center in Madhya Pradesh, India. The documented case holds immense practical importance for clinical practice because the currently available medical literature rarely explores the seamless integration of advanced physical interventional strategies with targeted pharmacological central desensitization. A 73-year-old woman suffering from severe, lancinating axillary pain five months after a shingles outbreak initially underwent preoperative blood profiling and continuous monitoring before receiving targeted thoracic DRG PRFA. Central desensitisation sequential to pulsed radiofrequency ablation of thoracic dorsal root ganglion in refractory postherpetic neuralgia: A case report.